Skip to main content
SpringerLink
Log in

In all, Wall Street supports biotech acquisitions

  • News and Commentary
  • Published:
Bio/Technology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Author notes

  1. Fariba Fischel Ghodsian is vice president and biotechnology/phar-maceuticals analyst at Wedbush Morgan Securities (Los Angeles, CA). Darby Heidemann, a research assistant at Webush Morgan Securities, contributed to this commentary.

    • Fariba Fischel Ghodsian
Authors
  1. Fariba Fischel Ghodsian
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghodsian, F. In all, Wall Street supports biotech acquisitions. Nat Biotechnol 13, 729–730 (1995). https://doi.org/10.1038/nbt0895-729

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0895-729

  • Springer Nature America, Inc.

Search

Navigation